New User? Sign Up | Sign In

Insider Trading - Axovant Gene Therapies Ltd. (AXGT)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
AXGT Insider Trading Transactions for Axovant Gene Therapies Ltd.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-06-14
Purchase
2019-06-17
7:09 pm
Axovant Gene Therapies Ltd. AXGT Cheruvu Pavan
CEO
7,500 $5.21 $39,075 7,500
(Direct)
View
2019-06-14
Purchase
2019-06-17
7:05 pm
Axovant Gene Therapies Ltd. AXGT Pande Atul
Director
3,370 $5.221 $17,595 3,370
(Direct)
View
2019-03-18
Purchase
2019-03-19
5:15 pm
Axovant Sciences Ltd. AXON QVT Associates GP LLC
QVT Financial Investment Cayman Ltd.
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Indirect)
View
2019-03-18
Purchase
2019-03-19
5:06 pm
Axovant Sciences Ltd. AXON VIKING GLOBAL PERFORMANCE LLC
Viking Global Equities LP
Viking Global Equities II LP
VGE III Portfolio Ltd.
Viking Global Equities Master Ltd.
Viking Long Fund Master Ltd.
Viking Long Fund GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Indirect)
View
2019-03-18
Purchase
2019-03-19
5:04 pm
Axovant Sciences Ltd. AXON Dexxon Holdings Ltd.
Dexcel Pharma Technologies Ltd.
Oren Dan
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Indirect)
View
2019-03-18
Purchase
2019-03-19
5:03 pm
Axovant Sciences Ltd. AXON Machado Patrick
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Indirect)
View
2019-03-18
Purchase
2019-03-19
5:03 pm
Axovant Sciences Ltd. AXON VIKING GLOBAL INVESTORS LP
Viking Global Opportunities Illiquid Investments Sub-Master LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Indirect)
View
2019-03-18
Purchase
2019-03-19
4:52 pm
Axovant Sciences Ltd. AXON SVF Investments (UK) Ltd
SVF GP (Jersey) Ltd
SoftBank Vision Fund L.P.
SVF Holdings (UK) LLP
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Indirect)
View
2019-03-18
Purchase
2019-03-19
4:49 pm
Axovant Sciences Ltd. AXON Lo Andrew
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Indirect)
View
2019-03-18
Purchase
2019-03-19
4:18 pm
Axovant Sciences Ltd. AXON Roivant Sciences Ltd.
10% Owner
6,666,667 $1.5 $10,000,001 105,952,384
(Direct)
View
2018-12-18
Purchase
2018-12-20
09:38 am
Axovant Sciences Ltd. AXON VIKING GLOBAL PERFORMANCE LLC
Viking Global Equities LP
Viking Global Equities II LP
VGE III Portfolio Ltd.
Viking Long Fund Master Ltd.
Viking Long Fund GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Indirect)
View
2018-12-18
Purchase
2018-12-20
09:37 am
Axovant Sciences Ltd. AXON VIKING GLOBAL INVESTORS LP
Viking Global Opportunities Illiquid Investments Sub-Master LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Indirect)
View
2018-12-18
Purchase
2018-12-20
08:57 am
Axovant Sciences Ltd. AXON Lo Andrew
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Indirect)
View
2018-12-18
Purchase
2018-12-20
07:29 am
Axovant Sciences Ltd. AXON Dexxon Holdings Ltd.
Dexcel Pharma Technologies Ltd.
Oren Dan
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Indirect)
View
2018-12-18
Purchase
2018-12-20
07:06 am
Axovant Sciences Ltd. AXON SVF Investments (UK) Ltd
SVF GP (Jersey) Ltd
SoftBank Vision Fund L.P.
SVF Holdings (UK) LLP
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Indirect)
View
2018-12-18
Purchase
2018-12-20
06:15 am
Axovant Sciences Ltd. AXON QVT Associates GP LLC
QVT Offshore Ltd.
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Indirect)
View
2018-12-18
Purchase
2018-12-20
06:03 am
Axovant Sciences Ltd. AXON Machado Patrick
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Indirect)
View
2018-12-18
Purchase
2018-12-20
06:02 am
Axovant Sciences Ltd. AXON Roivant Sciences Ltd.
10% Owner
10,000,000 $1 $10,000,000 99,285,712
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-09-21
Option Award
2019-09-24
5:15 pm
N/A
N/A
Axovant Gene Therapies Ltd. AXGT Corcoran Gavin
VP
32,003 $0 32,003
(Direct)
View
2019-09-21
Option Award
2019-09-24
5:15 pm
N/A
N/A
Axovant Gene Therapies Ltd. AXGT Nassif David W.
Principal Financial Officer
30,120 $0 30,120
(Direct)
View
2019-09-21
Option Award
2019-09-24
5:14 pm
N/A
N/A
Axovant Gene Therapies Ltd. AXGT Cheruvu Pavan
Principal Executive Officer
45,181 $0 45,181
(Direct)
View
2019-07-01
Option Award
2019-07-02
6:15 pm
N/A
2029-06-30
Axovant Gene Therapies Ltd. AXGT Nassif David W.
Principal Financial Officer
150,000 $6.42 150,000
(Direct)
View
2019-07-01
Option Award
2019-07-02
6:15 pm
N/A
2029-06-30
Axovant Gene Therapies Ltd. AXGT Nassif David W.
Principal Financial Officer
75,000 $6.42 150,000
(Direct)
View
2019-06-27
Option Award
2019-07-01
6:06 pm
N/A
2029-06-26
Axovant Gene Therapies Ltd. AXGT Sundaram Senthil Vel
Director
18,750 $6.19 18,750
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:21 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Pande Atul
Director
255,000 $1.06 255,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:20 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Bickerstaff George
Director
255,000 $1.06 255,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:19 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT POTTER MYRTLE S
Director
255,000 $1.06 255,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:18 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Torti Frank
Director
255,000 $1.06 255,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:17 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Corcoran Gavin
VP
767,000 $1.06 767,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:17 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Corcoran Gavin
VP
200,000 $1.06 767,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:15 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Modig Berndt
Director
255,000 $1.06 255,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:14 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Cheruvu Pavan
CEO
1,596,000 $1.06 1,596,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:14 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Cheruvu Pavan
CEO
1,596,000 $1.06 1,596,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:13 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Bazley Mathew C.
General Counsel
726,000 $1.06 726,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:13 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT Bazley Mathew C.
General Counsel
250,000 $1.06 726,000
(Direct)
View
2019-04-15
Option Award
2019-04-17
9:11 pm
N/A
2029-04-14
Axovant Sciences Ltd. AXGT JEFFS ROGER
Director
255,000 $1.06 255,000
(Direct)
View
2018-10-15
Option Award
2018-10-16
6:05 pm
N/A
2028-10-14
Axovant Sciences Ltd. AXON POTTER MYRTLE S
Director
150,000 $2.37 150,000
(Direct)
View
Goto page 0, 1, Next